You're made of trillions of something—and it isn't you

The Ten-to-One Myth and How It Fell Apart

The idea that bacteria outnumber human cells by a factor of ten became scientific gospel in the 1970s, repeated in textbooks, TED Talks, and popular science writing for decades. The claim originated with a 1972 paper by microbiologist Thomas Luckey, who estimated bacterial counts in the gut based on sparse data and rough extrapolations. No one questioned the math until 2016, when Ron Sender, Shai Fuchs, and Ron Milo at Israel's Weizmann Institute of Science decided to scrutinize every assumption. They recalculated cell counts using modern measurements of colon volume, bacterial density per gram of feces, and updated estimates of human cell numbers—particularly red blood cells, which constitute the vast majority of our cellular inventory. Their conclusion, published in *PLOS Biology*, startled the field: a 70-kilogram reference male contains roughly 38 trillion bacteria and 30 trillion human cells, a ratio closer to 1.3:1 than 10:1. The correction mattered not just for accuracy but because it reframed the microbiome as a substantial but not overwhelming presence, one that evolved in tandem with human physiology rather than colonizing it as an afterthought.

The Weizmann team's work revealed how fragile the ten-to-one figure had always been. Luckey's original estimate treated the gut as a uniform cylinder and assumed bacterial density remained constant from stomach to rectum, neither of which holds true. Modern imaging shows the colon harbors 95 percent of gut bacteria, with the small intestine and stomach containing far fewer microbes due to acidity, bile salts, and rapid transit times. The researchers also corrected the human cell count: earlier estimates undercounted red blood cells, which live only 120 days and turn over constantly, and overcounted other cell types. When they factored in cell lifespan and organ mass, the human side of the ledger grew. The final ratio depends on individual variation—body mass, recent bowel movements, and even hydration levels shift the balance—but the days of the ten-fold myth are over. The correction spread quickly through the scientific literature, though popular culture has been slower to catch up; articles still cite the old figure, and the phrase "we're more bacteria than human" persists in casual conversation despite being demonstrably false.

What the Microbiome Actually Does

Those 38 trillion bacterial cells—though roughly equal in number to our own—weigh only about 200 grams, less than half a pound, because bacteria are far tinier than human cells. Yet their collective genetic material dwarfs ours: the microbiome contains some 3 million unique genes compared to the roughly 20,000 in the human genome, giving it metabolic capabilities our cells lack. Gut bacteria synthesize vitamins like B12 and K2, break down complex plant fibers into short-chain fatty acids that nourish colon cells, and train the immune system to distinguish friend from foe. Germ-free mice raised in sterile bubbles develop stunted immune systems and oversized ceca, demonstrating that microbial input is essential for normal development. Researchers at Caltech and Harvard have shown that gut bacteria also produce neurotransmitter precursors—serotonin, dopamine, gamma-aminobutyric acid—that influence mood and behavior, earning the microbiome the nickname "the second brain." Studies link microbial diversity to outcomes ranging from obesity and diabetes to depression and autoimmune disease, though cause-and-effect remains murky.

The composition of the microbiome shifts dramatically across the lifespan. Newborns acquire their first microbes during vaginal birth, swallowing bacteria from the mother's birth canal; cesarean-section infants instead pick up skin bacteria from hospital staff, a difference that may influence immune development. Breastfeeding seeds the gut with *Bifidobacterium* species that digest milk oligosaccharides, while formula feeding tilts the balance toward *Enterobacteriaceae*. By age three, a child's microbiome resembles an adult's, dominated by *Bacteroidetes* and *Firmicutes* phyla that specialize in breaking down dietary fiber. Diet remains the strongest modulator: high-fiber diets favor bacteria that produce butyrate, a fatty acid linked to colon health, while low-fiber Western diets starve those species and promote blooms of mucus-degrading bacteria that may erode the gut lining. Antibiotics can wipe out entire bacterial lineages, sometimes permanently, a risk doctors now weigh more carefully when prescribing broad-spectrum drugs. Fecal microbiota transplants—once a fringe therapy—have become standard treatment for recurrent *Clostridium difficile* infections, with success rates above 90 percent, and researchers are testing the approach for inflammatory bowel disease, metabolic syndrome, and even neurological disorders.

The Evolutionary Partnership

Humans and bacteria share a 500-million-year co-evolutionary history, dating back to the first vertebrate guts. The relationship is mutualistic: we provide bacteria with a warm, nutrient-rich habitat and a steady flow of food; they provide us with digestive enzymes, immune education, and competition against pathogens. The gut's mucus layer, secreted by goblet cells, acts as a spatial buffer, keeping bacteria at arm's length while allowing nutrient exchange. Specialized immune cells called M cells sample bacterial antigens and present them to lymphoid tissue in the gut wall, training T and B cells to tolerate beneficial microbes while mounting defenses against invaders. This immune tuning begins in infancy and continues throughout life, a process disrupted by sterile modern environments and overuse of antimicrobials. The "hygiene hypothesis," first proposed in 1989 by epidemiologist David Strachan, suggests that reduced microbial exposure in childhood contributes to rising rates of allergies, asthma, and autoimmune diseases in industrialized countries, though the hypothesis remains contentious.

Not all gut bacteria are benign. Opportunistic species like *Escherichia coli* and *Enterococcus faecalis* can cause infections if they breach the gut barrier, and imbalances in microbial composition—termed dysbiosis—are implicated in inflammatory bowel disease, colon cancer, and metabolic disorders. The microbiome's influence extends beyond the gut: oral bacteria linked to periodontal disease have been found in atherosclerotic plaques, and skin bacteria modulate inflammation in eczema and acne. Researchers at the University of Chicago discovered that gut bacteria influence the effectiveness of cancer immunotherapy drugs, with patients harboring certain *Bifidobacterium* species responding better to checkpoint inhibitors. The findings have spurred a cottage industry of probiotic supplements and "microbiome-friendly" diets, though evidence remains mixed; most probiotics pass through the gut without colonizing, and their health effects are strain-specific and poorly understood. The field is moving toward personalized microbiome interventions—tailored probiotics, prebiotics, or dietary changes based on an individual's microbial profile—but clinical applications remain years away. What is clear is that the one-to-one ratio of bacterial to human cells is no coincidence: it reflects a partnership millions of years in the making, one in which neither party can thrive alone.